Dexmedetomidine Use in the Emergency Department

Primary Indications and Patient Selection

The American College of Emergency Medicine recognizes dexmedetomidine as an acceptable agent for procedural sedation in the ED, though emergency physicians must be familiar with its use and prepared to manage complications 2, 4
Dexmedetomidine is most frequently used for light sedation where the patient needs to remain arousable and cooperative 1, 3
Ideal candidates for dexmedetomidine include patients requiring light to moderate sedation who need to remain arousable, mechanically ventilated patients in acute respiratory failure, and patients requiring sedation with minimal respiratory depression 1, 3, 6

The standard loading dose is 1 μg/kg IV over 10 minutes, but this should be avoided in hemodynamically unstable patients due to the risk of biphasic cardiovascular response 1, 5
The maintenance infusion should start at 0.2-0.7 μg/kg/hour and may be titrated up to 1.5 μg/kg/hour as tolerated 1

Continuous hemodynamic monitoring is mandatory, and blood pressure and heart rate should be monitored closely, especially during loading dose and dose increases 1, 5
Regular sedation assessment using validated scales is also necessary 1, 5

Hypotension occurs in 39.8-40% of ED patients, usually resolving without intervention, but may require reducing the infusion rate 1, 5
Bradycardia occurs in 17-18% of patients, typically resolving with dose reduction, and monitoring for progression to heart block is necessary 1, 6

Patients with severe hepatic dysfunction have impaired clearance and require lower doses 1, 5
Dexmedetomidine has opioid-sparing effects, reducing narcotic requirements 1
Minimal respiratory depression is observed compared to benzodiazepines and opioids, but loss of oropharyngeal muscle tone can lead to airway obstruction in non-intubated patients 1, 3, 5